Cita APA (7a ed.)

Reiter, R. J., Cardinali, D. P., Neel, R. L., Domínguez Rodriguez, A., Brown, G. M., & Tesarik, J. (2022). Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2. ST-Bio-Life LLC.

Cita Chicago Style (17a ed.)

Reiter, Russel J., Daniel Pedro Cardinali, Richard L. Neel, Alberto Domínguez Rodriguez, Gregory M. Brown, y Jan Tesarik. Rationale for the Continued Use of Melatonin to Combat the Delta Variant of SARS-CoV-2. ST-Bio-Life LLC, 2022.

Cita MLA (8a ed.)

Reiter, Russel J., et al. Rationale for the Continued Use of Melatonin to Combat the Delta Variant of SARS-CoV-2. ST-Bio-Life LLC, 2022.